• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
VHL
Click for more information
7.69% 14.0¢

VIRAX HOLDINGS LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
VHL
Ann: Prescient completes acquisition of AKTivate Therapeutics 		14/12/14 7 4.8K
14/12/14 Last post  caketin Comments Created with Sketch.  7  Views Created with Sketch.  4.8K 
VHL
Why is Engle doubling Hopper's pay? 		12/12/14 2 1.2K
12/12/14 Last post  Biarra Comments Created with Sketch.  2  Views Created with Sketch.  1.2K 
VHL
Ann: s708A Notice & Appendix 3B 		11/12/14 0 579
11/12/14 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  579 
VHL
Not Listed 		09/12/14 23 8.2K
09/12/14 Last post  P1 Comments Created with Sketch.  23  Views Created with Sketch.  8.2K 
VHL
Ann: Completion of Capital Consolidation 		05/12/14 0 587
05/12/14 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  587 
VHL
i call those guys sharesholders mollesters 		05/12/14 2 1.2K
05/12/14 Last post  caketin Comments Created with Sketch.  2  Views Created with Sketch.  1.2K 
VHL
Ann: Initial Director's Interest Notices 		03/12/14 0 487
03/12/14 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  487 
VHL
Ann: Final Director's Interest Notices 		03/12/14 0 503
03/12/14 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  503 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.